A study on dexmethasone as an adjuvant to 0.2% Ropivacaine in USG guided preemptive caudal epidural block for peri operative analgesia in patients undergoing lumbar spine surgeries
Phase 2
- Conditions
- Health Condition 1: 3- AdministrationHealth Condition 2: 3- AdministrationHealth Condition 3: 3- Administration
- Registration Number
- CTRI/2022/09/045813
- Lead Sponsor
- Dr Sitara A Y
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients belonging to ASA I,II.
2. Patients who give informed written consent.
Exclusion Criteria
1.Patients refusal for study, patients who underwent a previous lumbar spine surgery
2. Patients with a contraindication to regional anaesthesia
3. Patients with hypersensitivity to ropivacaine.
4. Patients with known cardiac, renal, hepatic, neurological disorders that would interfere with cardiovascular response assessment.
5. Patients with spine abnormalities and body dysmorphism.
6. Patients with coagulopathy or on any anti coagulants.
7. Use of benzodiazepines, anticonvulsants, alcohol, opioids or other psychotropic drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare intraoperative opioid consumption <br/ ><br>To compare duration of analgesiaTimepoint: 6-48hrs
- Secondary Outcome Measures
Name Time Method To compare the hemodynamic changes <br/ ><br>To compare adverse effectsTimepoint: 6-48hrs